Abstract
Mesenchymal tumors of the lung are rare. Malignant mesenchymal tumors are even rarer compared to their benign counterparts. Most often sarcomas seen in the lung are metastatic, although in very rare instances a leiomyosarcoma might also arise locally in the bronchus. Other sarcomas can be seen combined with carcinomas such as carcinosarcoma. There are a few exceptions, such as angiogenic tumors. These will be discussed here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Kitaichi M, Nagai S, Nishimura K, Itoh H, Asamoto H, Izumi T, Dail DH. Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. Eur Respir J. 1998;12:89–96.
Cheuk W, Wong KO, Wong CS, Dinkel JE, Ben-Dor D, Chan JK. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol. 2004;121:335–42.
Stacher E, Gruber-Mosenbacher U, Halbwedl I, Dei Tos AP, Cavazza A, Papotti M, Carvalho L, Huber M, Ermert L, Popper HH. The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets? Lung Cancer. 2009;65:49–55.
Miettinen M, Wang ZF. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors. Am J Surg Pathol. 2012;36:351–9.
Lamar JM, Motilal Nehru V, Weinberg G. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma. Cancers (Basel). 2018;10.
Miettinen M, Rikala MS, Rys J, Lasota J, Wang ZF. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors. Am J Surg Pathol. 2012;36:629–39.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Popper, H., Murer, B. (2020). Malignant Mesenchymal Tumors. In: Pulmonary Pathology. Essentials of Diagnostic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-22664-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-22664-0_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22662-6
Online ISBN: 978-3-030-22664-0
eBook Packages: MedicineMedicine (R0)